"87 Experimental Therapies For Gliobastoma Are In The Works, Some Might Help McCain Now" - Sharon Begley
Glioblastoma, the brain cancer that Senator John McCain has, is invariably described as aggressive and as having a poor prognosis. Recent advances, however, have persuaded some scientists that effective treatments are on the horizon – and some might even help McCain live longer than earlier patients did. Glioblastomas “have little tentacles growing into the normal brain that are challenging to see even with a microscope,” said Costas Hadjipanayis, MD, surgical neuro-oncologist at Mount Sinai Beth Israel and director of neurological oncology for the Mount Sinai Health System. When a patient drink the new agent, called Gleolan, three to five hours before surgery, it “allows us to visualize those fingers of tumor tissue,” Dr. Hadjipanayis added.
- Constantinos Hadjipanayis, MD, PhD, Site Chair, Neurosurgery, Mount Sinai Beth Israel, Professor, Neurosurgery, Oncological Sciences, Icahn School of Medicine at Mount Sinai
Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
Jan 02, 2020 View All Press Releases